Eastern Hepatobiliary Surgery Hospital
🇨🇳China
The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene
Completed
- Conditions
- Hepatocellular Carcinoma;Radical Hepatic Resection;
- First Posted Date
- 2013-02-08
- Last Posted Date
- 2016-04-01
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT01786980
- Locations
- 🇨🇳
Eastern Hepatobiliary Surgery Hospital, Shanghai, Shanghai, China
🇨🇳Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)
Not Applicable
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2012-07-18
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT01643447
- Locations
- 🇨🇳
Eastern Hepatobiliary Surgery Hospital, Shanghai, Shanghai, China
Prospective Randomized Study of Glucocorticoids in the Impact of the Liver Function and the Prognosis After Hepatectomy of HCC
Suspended
- Conditions
- Some Studies Shows That the Steroid Can Reduce the Injury of the I/R of the Liver
- Interventions
- First Posted Date
- 2012-05-31
- Last Posted Date
- 2012-05-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT01608945
A Study of Anterior Approach Combined With Infrahepatic Inferior Vena Cava Clamping
Not Applicable
- Conditions
- Blood LossSurgical Approach & Incisions
- Interventions
- Procedure: IVC clamping
- First Posted Date
- 2012-05-31
- Last Posted Date
- 2015-08-06
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01608386
A Trial of Complete Versus Selective HepaticVascular Clamping in Hepatectomy
Not Applicable
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Procedure: Pringle's ManeuverProcedure: Portal vein occlusionProcedure: Hemihepatic vascular Clamping
- First Posted Date
- 2009-02-26
- Last Posted Date
- 2016-04-01
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 320
- Registration Number
- NCT00851968
- Locations
- 🇨🇳
Eastern Hepatobiliary Surgery Hospital, Shanghai, Shanghai, China
Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients
Phase 2
Completed
- Conditions
- Hepatocellular CarcinomaPortal Vein Tumor Thrombus
- Interventions
- Drug: treatment with CBP and 5-FUDrug: treatment with endostar, CBP and 5-FU
- First Posted Date
- 2009-02-23
- Last Posted Date
- 2016-04-01
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT00849264
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC
Not Applicable
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Procedure: TACEProcedure: PVE
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2016-04-01
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT00834158
- Locations
- 🇨🇳
Eastern Hepatobiliary Surgery Hospital, Shanghai, China
Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular Carcinoma
Phase 4
Completed
- Conditions
- Unresectable Hepatocellular Carcinoma
- Interventions
- Procedure: Transcatheter arterial chemoembolization
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2016-04-01
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT00829465
Total Hemihepatic Vascular Exclusion in Hepatectomy in Hepatocellular Carcinoma Treatment
Not Applicable
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Procedure: Hemihepatic vascular ClampingProcedure: Pringle's ManeuverProcedure: Total hemihepatic vascular exclusion
- First Posted Date
- 2009-01-22
- Last Posted Date
- 2016-04-01
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT00827047
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma
Phase 2
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Drug: LMWHProcedure: TACE
- First Posted Date
- 2009-01-22
- Last Posted Date
- 2016-04-01
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT00827554
- Locations
- 🇨🇳
Eastern Hepatobiliary Surgery Hospital, ShangHai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath